These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 6636035

  • 1. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
    Hornby EJ, Perry CR.
    Thromb Haemost; 1983 Aug 30; 50(2):586-7. PubMed ID: 6636035
    [Abstract] [Full Text] [Related]

  • 2. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 2000 Apr 30; 65(4):427-30. PubMed ID: 10810178
    [Abstract] [Full Text] [Related]

  • 3. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
    Honey AC, Lad N, Tuffin DP.
    Thromb Haemost; 1986 Aug 20; 56(1):80-5. PubMed ID: 3775692
    [Abstract] [Full Text] [Related]

  • 4. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F, Joseph D, Touqui L, Vargaftig BB.
    Thromb Haemost; 1985 Feb 18; 53(1):99-104. PubMed ID: 3992525
    [Abstract] [Full Text] [Related]

  • 5. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB, Joseph D, Marlas G, Chevance LG.
    Thromb Haemost; 1982 Aug 24; 48(1):67-71. PubMed ID: 7135345
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 1999 Jun 24; 64(6):631-5. PubMed ID: 10395976
    [Abstract] [Full Text] [Related]

  • 7. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y.
    Rinsho Byori; 1994 Jan 24; 42(1):63-9. PubMed ID: 8107285
    [Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
    Sturk A, Schaap MC, ten Cate JW, Heymans HS, Schutgens RB, Przyrembel H, Borst P.
    J Clin Invest; 1987 Feb 24; 79(2):344-50. PubMed ID: 3805272
    [Abstract] [Full Text] [Related]

  • 9. Platelet aggregation in response to collagen and thrombin reliably detects the ingestion of low-dose aspirin.
    Müller TH, Schmidt S, Schunter F, Reil GH.
    Beitr Infusionsther Transfusionsmed; 1997 Feb 24; 34():105-9. PubMed ID: 9356662
    [Abstract] [Full Text] [Related]

  • 10. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G, Kertscher HP, Till U.
    Biomed Biochim Acta; 1985 Feb 24; 44(2):K17-23. PubMed ID: 4004829
    [Abstract] [Full Text] [Related]

  • 11. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F, Bachelot C, Molle D, Caen J, Guez D.
    J Cardiovasc Pharmacol; 1993 Feb 24; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C, Maiolo A, Tua A, Grignani G.
    Haematologica; 2000 Aug 24; 85(8):820-5. PubMed ID: 10942928
    [Abstract] [Full Text] [Related]

  • 14. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
    Suzuki Y, Miwa M, Harada M, Matsumoto M.
    Eur J Biochem; 1988 Feb 15; 172(1):117-20. PubMed ID: 3345757
    [Abstract] [Full Text] [Related]

  • 19. The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin.
    Hallam TJ, Scrutton MC, Wallis RB.
    FEBS Lett; 1983 Oct 03; 162(1):142-6. PubMed ID: 6617886
    [Abstract] [Full Text] [Related]

  • 20. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).
    Cargill DI, Cohen DS, Van Valen RG, Klimek JJ, Levin RP.
    Thromb Haemost; 1983 Jun 28; 49(3):204-7. PubMed ID: 6879508
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.